J Dawe
Dados Biográficos
| ID | 7448121 |
|---|---|
| NOME | J Dawe |
| PRENOMES | J |
| SOBRENOME | Dawe |
| ASSINATURA | DAWE J |
| AFILIAÇÕES | Burnet Institute |
| ORCID | 0000-0002-3227-9849 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 1997 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria , Australia , 2015 to 2023
Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland
Benzodiazepine use is common among PWIO in England, Wales, and Northern Ireland, and is associated with higher prevalence of non-fatal overdose. These findings underscore the need to strengthen overdose prevention and harm reduction efforts addressing benzodiazepine use across the UK
The health effects of non‐prescribed anabolic–androgenic steroid use
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C
Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings
Providing outreach hepatitis C services in community-based services was effective in engaging people living with and at-risk of hepatitis C, in education, testing, and care. Nurse-led, person-centred care was critical to the success of the project. Our evaluation underscores the importance of employing a partnership approach when delivering hepatitis C models of care in community settings, and incorporating workforce education and capacity-buildi…
Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020
Healthy Aging
B. Payne, J. Dawe, R. Evans, V. Marshall, P. Clarke, D. Norris, J. Hagey, E. Shapiro, R. Wilkins, B. Havens, Healthy Aging: Insights for Research and Policy, Canadian Public Policy / Analyse de Politiques, Vol. 23, Special Joint Issue: Aging / Vieillissement (Spring, 1997), pp. 42-52
Sem obras proeminentes nesta página.
Healthy Aging
B. Payne, J. Dawe, R. Evans, V. Marshall, P. Clarke, D. Norris, J. Hagey, E. Shapiro, R. Wilkins, B. Havens, Healthy Aging: Insights for Research and Policy, Canadian Public Policy / Analyse de Politiques, Vol. 23, Special Joint Issue: Aging / Vieillissement (Spring, 1997), pp. 42-52
Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020
Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings
Providing outreach hepatitis C services in community-based services was effective in engaging people living with and at-risk of hepatitis C, in education, testing, and care. Nurse-led, person-centred care was critical to the success of the project. Our evaluation underscores the importance of employing a partnership approach when delivering hepatitis C models of care in community settings, and incorporating workforce education and capacity-buildi…
The health effects of non‐prescribed anabolic–androgenic steroid use
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C
Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria , Australia , 2015 to 2023
Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland
Benzodiazepine use is common among PWIO in England, Wales, and Northern Ireland, and is associated with higher prevalence of non-fatal overdose. These findings underscore the need to strengthen overdose prevention and harm reduction efforts addressing benzodiazepine use across the UK
Internal Medicine (5 obras) · Medicine (5 obras) · Family medicine (2 obras) · Hepatitis (2 obras) · Hepatitis B Virus Studies (2 obras) · Hepatitis C (2 obras) · Hepatitis C virus research (2 obras) · HIV, Drug Use, Sexual Risk (2 obras) · Medical prescription (2 obras) · Opioid Use Disorder Treatment (2 obras)